Drugmaker Novartis is weighing whether to sell assets from its radiopharmaceuticals unit, Advanced Accelerator Applications, Bloomberg reported Tuesday citing unnamed sources with knowledge of the matter.
The Swiss company is already is in the initial stages of seeking buyers for some of its imaging products, used for diagnosing certain cancers, cardiovascular and neurological disorders.
“Deliberations are ongoing and there’s no certainty they’ll result in any transaction,” Bloomberg wrote Oct. 3, while noting that Novartis declined to comment on the report.
Read more from the news outlet at the link below (subscription required).
Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic.